Reliability and Reproducibility of Antinuclear Antibody Testing in Pediatric Rheumatology Practice

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2023 Jan 30

PMID 36714114

Authors

Barbara E Ostrov

Affiliations

Soon will be listed here.

Abstract

Antinuclear antibody (ANA) testing is common practice among health care practitioners when evaluating children and adolescents with non-specific symptoms including fatigue and aches and pains. When positive, ANA results often lead to referrals to pediatric rheumatologists as these antibodies may be key indicators for specific pediatric rheumatologic diagnoses. The reliability and reproducibility of ANA tests varies with assay techniques and validation and interpretation of results. In the following article, review of ANA testing in pediatrics is provided along with case examples that demonstrate the reliability and reproducibility of these results in specific scenarios common in the practice of pediatric rheumatology. Guidelines for more accurate utilization of ANA testing are presented with the aim to improve testing and interpretation by ordering clinicians.

Citing Articles

InTiCAR: Network-based identification of significant inter-tissue communicators for autoimmune diseases.

Kim K, Han M, Lee D Comput Struct Biotechnol J. 2025; 27:333-345.

PMID: 39897058 PMC: 11782887. DOI: 10.1016/j.csbj.2025.01.003.

Should We Adopt Increased Dilutions for Indirect Immunofluorescence in Pediatric Anti-Centromere Antibody Testing? Insights from a Three-Year Retrospective Study.

Soylu M, Taskin R, Aytac G, Aksu G, Durmaz S, Karakoyun M Children (Basel). 2025; 12(1).

PMID: 39857867 PMC: 11763642. DOI: 10.3390/children12010036.

National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients.

Branton S, Stubbs L, Havrilla H, Torok K J Scleroderma Relat Disord. 2024; :23971983241272460.

PMID: 39544906 PMC: 11559527. DOI: 10.1177/23971983241272460.

References

Gordon M, Porter D . Minocycline induced lupus: case series in the West of Scotland. J Rheumatol. 2001; 28(5):1004-6. View

Hetlevik S, Flato B, Rygg M, Nordal E, Brunborg C, Hetland H . Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. Ann Rheum Dis. 2016; 76(1):159-165. DOI: 10.1136/annrheumdis-2016-209522. View

Hilario M, Len C, Roja S, Terreri M, Almeida G, Andrade L . Frequency of antinuclear antibodies in healthy children and adolescents. Clin Pediatr (Phila). 2004; 43(7):637-42. DOI: 10.1177/000992280404300709. View

Copple S, Martins T, Masterson C, Joly E, Hill H . Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera. Ann N Y Acad Sci. 2007; 1109:464-72. DOI: 10.1196/annals.1398.052. View

Deane P, Liard G, Siegel D, Baum J . The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics. 1995; 95(6):892-5. View

Freudenhammer M, Salzer U, Heselich A, Hufnagel M, Janda A . Low Prevalence of Anti-DFS70 Antibodies in Children With ANA-Associated Autoimmune Disease. Front Pediatr. 2022; 10:839928. PMC: 8980602. DOI: 10.3389/fped.2022.839928. View

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R . 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019; 78(9):1151-1159. DOI: 10.1136/annrheumdis-2018-214819. View

Gran J, Husby G . HLA-B27 and spondyloarthropathy: value for early diagnosis?. J Med Genet. 1995; 32(7):497-501. PMC: 1050539. DOI: 10.1136/jmg.32.7.497. View

Meier H, Sandler D, Wilkerson J, Miller F, Dinse G, Parks C . Hygiene Hypothesis Indicators and Prevalence of Antinuclear Antibodies in US Adolescents. Front Immunol. 2022; 13:789379. PMC: 8832391. DOI: 10.3389/fimmu.2022.789379. View

10.

Pisetsky D, Lipsky P . New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol. 2020; 16(10):565-579. PMC: 8456518. DOI: 10.1038/s41584-020-0480-7. View

11.

Cabral D, Petty R, Fung M, Malleson P . Persistent antinuclear antibodies in children without identifiable inflammatory rheumatic or autoimmune disease. Pediatrics. 1992; 89(3):441-4. View

12.

Mohammed A, Boddu P, Mael D, Samee M, Villines D . Inappropriate use of commercial Antinuclear Antibody Testing in a community-based US hospital: a retrospective study. J Community Hosp Intern Med Perspect. 2016; 6(4):32031. PMC: 5016776. DOI: 10.3402/jchimp.v6.32031. View

13.

Dellavance A, Viana V, Leon E, Bonfa E, Andrade L, Leser P . The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern. J Rheumatol. 2005; 32(11):2144-9. View

14.

Torok K, Arkachaisri T . Autoimmune thyroiditis in antinuclear antibody positive children without rheumatologic disease. Pediatr Rheumatol Online J. 2010; 8:15. PMC: 2881083. DOI: 10.1186/1546-0096-8-15. View

15.

Naides S, Genzen J, Abel G, Bashleben C, Ansari M . Antinuclear Antibodies Testing Method Variability: A Survey of Participants in the College of American Pathologists' Proficiency Testing Program. J Rheumatol. 2020; 47(12):1768-1773. DOI: 10.3899/jrheum.190933. View

16.

Weaver L, Behrens E . How to use... antinuclear antibodies in paediatric rheumatic diseases. Arch Dis Child Educ Pract Ed. 2013; 98(2):64-70. DOI: 10.1136/archdischild-2012-303326. View

17.

Melegari A, Bonaguri C, Russo A, Luisita B, Trenti T, Lippi G . A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev. 2012; 11(10):713-6. DOI: 10.1016/j.autrev.2011.12.010. View

18.

Zou H, Gu X, Yu W, Wang Z, Jiao M . Detection of serum antinuclear antibodies in lymphoma patients. Genet Mol Res. 2015; 14(4):16546-52. DOI: 10.4238/2015.December.11.1. View

19.

Pain C, Constantin T, Toplak N, Moll M, Iking-Konert C, Piotto D . Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoring. Clin Exp Rheumatol. 2016; 34 Suppl 100(5):200-206. View

20.

Storwick J, Brett A, Buhler K, Chin A, Schmeling H, Johnson N . Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: A systematic review and meta-analysis. Autoimmun Rev. 2022; 21(6):103086. DOI: 10.1016/j.autrev.2022.103086. View